BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32612151)

  • 1. CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels.
    Taher TE; Bystrom J; Mignen O; Pers JO; Renaudineau Y; Mageed RA
    Cell Mol Immunol; 2020 Nov; 17(11):1201-1203. PubMed ID: 32612151
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.
    Soldevila G; Raman C; Lozano F
    Curr Opin Immunol; 2011 Jun; 23(3):310-8. PubMed ID: 21482089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte.
    Mageed RA; Garaud S; Taher TE; Parikh K; Pers JO; Jamin C; Renaudineau Y; Youinou P
    Autoimmun Rev; 2012 Sep; 11(11):795-8. PubMed ID: 22349614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5, an important regulator of lymphocyte selection and immune tolerance.
    Raman C
    Immunol Res; 2002; 26(1-3):255-63. PubMed ID: 12403363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
    Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
    Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
    Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
    Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.
    Yanaba K; Bouaziz JD; Matsushita T; Tsubata T; Tedder TF
    J Immunol; 2009 Jun; 182(12):7459-72. PubMed ID: 19494269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTK signaling drives CD1d
    Das S; Bar-Sagi D
    Oncogene; 2019 Apr; 38(17):3316-3324. PubMed ID: 30635655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation.
    Zuckerman E
    J Hepatol; 2003 May; 38(5):674-6. PubMed ID: 12713881
    [No Abstract]   [Full Text] [Related]  

  • 10. Normal CD5+ B lymphocytes are poor stimulators in the autologous mixed lymphocyte reaction (AMLR).
    Fernandez LA; Cheng R; Sadek I; Nevill TJ; Macsween JM
    Clin Exp Immunol; 1997 Jun; 108(3):557-61. PubMed ID: 9182907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis.
    Pers JO; Jamin C; Le Corre R; Lydyard PM; Youinou P
    Eur J Immunol; 1998 Dec; 28(12):4170-6. PubMed ID: 9862353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cells in the aged: CD27, CD5, and CD40 expression.
    Colonna-Romano G; Bulati M; Aquino A; Scialabba G; Candore G; Lio D; Motta M; Malaguarnera M; Caruso C
    Mech Ageing Dev; 2003 Apr; 124(4):389-93. PubMed ID: 12714244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of interleukin-10 in autoantibody production and in the fate of human cord blood CD5+ B lymphocytes.
    Villaseñor-Bustamante S; Alvarado-De La Barrera C; Richaud-Patin Y; Martínez-Ayala H; Llorente L
    Scand J Immunol; 1999 Jun; 49(6):629-32. PubMed ID: 10354374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells.
    Morikawa K; Torii I; Morikawa S
    Scand J Immunol; 2002 Jan; 55(1):44-52. PubMed ID: 11841691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15.
    Herndler-Brandstetter D; Brunner S; Weiskopf D; van Rijn R; Landgraf K; Dejaco C; Duftner C; Schirmer M; Kloss F; Gassner R; Lepperdinger G; Grubeck-Loebenstein B
    Hum Immunol; 2011 Aug; 72(8):627-31. PubMed ID: 21539877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.
    Azzam HS; Grinberg A; Lui K; Shen H; Shores EW; Love PE
    J Exp Med; 1998 Dec; 188(12):2301-11. PubMed ID: 9858516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The T/B cell antigen, CD5, and the B-cell surface protein, CD72, form a pair of interacting receptors.
    Van de Velde H; Von Hoegen I; Luo W; Parnes JR; Thielemans K
    Ann N Y Acad Sci; 1992 May; 651():443-52. PubMed ID: 1376061
    [No Abstract]   [Full Text] [Related]  

  • 18. The Ca2+/calmodulin-dependent kinase type IV is involved in the CD5-mediated signaling pathway in human T lymphocytes.
    Gringhuis SI; de Leij LF; Wayman GA; Tokumitsu H; Vellenga E
    J Biol Chem; 1997 Dec; 272(50):31809-20. PubMed ID: 9395527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively.
    Dutra WO; Colley DG; Pinto-Dias JC; Gazzinelli G; Brener Z; Pereira ME; Coffman RL; Correa-Oliveira R; Carvalho-Parra JF
    Scand J Immunol; 2000 Jan; 51(1):91-7. PubMed ID: 10632982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells.
    Sen G; Bikah G; Venkataraman C; Bondada S
    Eur J Immunol; 1999 Oct; 29(10):3319-28. PubMed ID: 10540344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.